
Sirnaomics Chairman Increases Stake, Signaling Confidence in Growth

I'm PortAI, I can summarize articles.
Sirnaomics Ltd.'s chairman, Dr. Poon Hung Fai, increased his stake by purchasing 100,000 shares at HK$6.83 each, raising his total shareholding to 16.44%. This move signals strong insider confidence in the company's growth prospects, potentially influencing investor sentiment positively. Sirnaomics focuses on RNAi therapeutics in the pharmaceutical industry. The latest analyst rating for its stock is Hold with a HK$7.50 price target.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.

